Fierce Pharma

JUNE 4, 2024

A little less than a year after Eli Lilly won the blessing of England's drug value watchdog for tirzepatide in Type 2 diabetes, the National Institute for Health and Care Excellence (NICE) has retu | A little less than a year after Eli Lilly won the blessing of England's drug value watchdog for tirzepatide in Type 2 diabetes, the National Institute for Health and Care Excellence (NICE) has returned with an endorsement in obesity.

325

325

MedCity News

JUNE 4, 2024

By working together to build an ecosystem of support around people with diabetes, the healthcare system as a whole can ensure that no one slips through the cracks. The post As Interest in GLP-1s Explodes, People Living With Diabetes Need Structured Support To Ensure Effective Use appeared first on MedCity News.

Healthcare 121

Healthcare Healthcare Biopharma Patients 121

Fierce Pharma

JUNE 4, 2024

For several months, a U.S. security crackdown on biopharma firms suspected to be linked to the Chinese Communist Party (CCP) has continued to gain steam. | For several months, a U.S. security crackdown on biopharma firms suspected to be linked to the Chinese Communist Party has continued to gain steam. Now, several new names could be feeling the heat.

Biopharma 306

Biopharma 306

MedCity News

JUNE 4, 2024

Abarca executives see plenty of potential for new technologies but note the need to strike the right balance between tech and human intervention. The post How AI and Machine Learning Can Transform Pharmacy Benefits Management appeared first on MedCity News.

Management 119

Management 119

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JUNE 4, 2024

After Amarin's tussle with investor group Sarissa Capital led to a restructuring and a board shuffle, the struggling drugmaker is undergoing its third CEO shake-up in just over a year.

278

278

PharmaTech

JUNE 4, 2024

Pharm Tech Group sits down with Bernard Sagaert, CEO of etherna, to examine the role of mRNA in the treatment of autoimmune diseases.

115

115

pharmaphorum

JUNE 4, 2024

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and analysts think uptake by patients is now poised to take off.

Marketing 115

Marketing FDA Patients 115

MedCity News

JUNE 4, 2024

With its financing round of $130 million, Sword Health is now valued at $3 billion. The company also unveiled Phoenix, an AI care specialist that guides users through sessions. The post Sword Health Secures $130M, Introduces AI Care Specialist appeared first on MedCity News.

115

115

pharmaphorum

JUNE 4, 2024

New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for accelerated approval before a phase 3 programme.

115

115

Pharmaceutical Technology

JUNE 4, 2024

Scientists at the NIH have introduced an AI tool to predict the response to immune checkpoint inhibitors for cancer patients.

Patients 112

Patients 112

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

JUNE 4, 2024

Sleep disturbances are one of the most common and disruptive symptoms in menopausal women, but not enough is known about the causes, and current sleep aids are often ineffective. To plug that gap, Germany’s Bayer has joined forces with electronics group Samsung to carry out an observational study on sleep disturbances during menopause (SDM), tapping into the South Korean company’s position as one of the world's largest producers of consumer electronics.

Electronics 111

Electronics 111

Pharmaceutical Technology

JUNE 4, 2024

Alligator Bioscience’s CEO says that its pancreatic cancer drug may mark a meaningful improvement on current treatment standards.

109

109

pharmaphorum

JUNE 4, 2024

FDA advisors voted against the use of Lykos Therapeutics’ MDMA-based therapy for PTSD, in a first regulatory test for the emerging psychedelics sector

FDA 109

FDA 109

Pharmaceutical Technology

JUNE 4, 2024

A June 2024 literature review has revealed that climate change has the potential to intensify MS symptoms, as well as the incidence, prevalence, and severity of other major neurological disorders.

98

98

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

European Pharmaceutical Review

JUNE 4, 2024

Eli Lilly and Company has announced its new Executive Vice President of Global Quality. This news follows a statement by the firm at the start of this year declaring the retirement of its long-serving current EVP. A new start at Eli Lilly Melissa Seymour will begin her new role as EVP at Eli Lilly on 22 July 2024. As part of this position, she will also serve as a member of the company’s Executive Committee.

Medicine 98

Medicine Pharmaceutical Leads Manufacturing 98

Pharmaceutical Technology

JUNE 4, 2024

Sarclisa is looking to make a dent in the anti-CD38 multiple myeloma treatment market dominated by J&J’s Darzalex.

Marketing 98

Marketing 98

European Pharmaceutical Review

JUNE 4, 2024

In an area covering almost 1,400m 2 , the Pharmaceutical Divisions of IMA Group and its specialists are glad to introduce IMA Pharma, the All-In-One supplier specialised in the design and manufacture of innovative machines and complete lines for the processing and packaging of pharmaceutical and nutraceutical products, medical devices assembling, as well as projects concerning digitalisation , sustainability, and customer service solutions.

Pharmaceutical 95

Pharmaceutical Pharma Manufacturing Training 95

Pharmaceutical Technology

JUNE 4, 2024

EryDex is being evaluated in the Phase III NEAT study which will enrol over 100 patients with rare disease ataxia-telangiectasia.

FDA 97

FDA Patients 97

Advertisement

PharmaTimes

JUNE 4, 2024

Positive clinical data from phase 1 study presented at ASCO annual meeting

92

92

Pharmaceutical Technology

JUNE 4, 2024

Monday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE) following a Delaware judge’s ruling on 31 May that over 72,000 lawsuits over discontinued heartburn drug Zantac, known generically as ranitidine, could go ahead.

97

97

MedCity News

JUNE 4, 2024

Hospitals’ finances improved in April compared to both the month prior and the same time frame last year, according to a new report from Kaufman Hall. The report also noted that there is a widening gap between the highest- and lowest-performing organizations. The post Hospital Operating Margins Are Growing — But Not For All appeared first on MedCity News.

Patients 88

Patients 88

PharmaTimes

JUNE 4, 2024

Collaboration yields promising Barriolide therapy Enterothelin

86

86

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTech

JUNE 4, 2024

Pharm Tech Group looks at the challenges surrounding the development and manufacture of ATMPs in more detail with Agne Vaitkeviciene, CEO of Memel Biotech.

Manufacturing 72

Manufacturing 72

Pharmacy Times

JUNE 4, 2024

The immunizing technicians stated they had greater job satisfaction and had a greater sense of being valuable pharmacy members

59

59

PharmaVoice

JUNE 4, 2024

From regulatory restrictions to evocative letter strings, branded drug naming is both an art and a science. We break down the process.

59

59

PharmExec

JUNE 4, 2024

As the digital and social media revolution continues to evolve, healthcare marketers must consider how to unlock the full potential of social with innovative engagement opportunities.

Marketing 52

Marketing Media Pharma Healthcare 52

Advertisement

Distribution

PharmaTech

JUNE 4, 2024

Webinar Date/Time: Thu, Jun 27, 2024 11:00 AM EDT

52

52

PharmExec

JUNE 4, 2024

After three years of study, the V940 and Keytruda combination demonstrated sustained benefits in recurrence-free survival and distant metastasis-free survival in patients with high-risk melanoma following complete resection.

Patients 52

Patients 52

Pharmaceutical Technology

JUNE 4, 2024

Discover key considerations for selecting pharmaceutical waist containers. Find out about the latest technology used in pharmaceutical closure systems.

Pharmaceutical 52

Pharmaceutical 52

PharmExec

JUNE 4, 2024

Reportedly, data from the IMROZ study marks the first time an anti-CD38 monoclonal antibody combined with standard-of-care therapy has demonstrated significant improvement in progression-free survival for newly diagnosed transplant-ineligible multiple myeloma.

Patients 52

Patients 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales